Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration

FASEB Journal

Volumn 22, Issue 9, 2008, Pages 3348-3357

  Wong, S L Alan ^a   Wing, Man Chan ^a   Chan, H Y Edwin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aggregate; Drosophila; Neurodegeneration; Solubility

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHAPERONE; DODECYL SULFATE SODIUM; HEAT SHOCK COGNATE PROTEIN 70; OLIGOMER; POLYGLUTAMINE;

ARTICLE; CONTROLLED STUDY; DEGENERATION; DROSOPHILA; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HSC70 HEAT-SHOCK PROTEINS; MICE; NEURODEGENERATIVE DISEASES; PEPTIDES; PROTEIN CONFORMATION; SODIUM DODECYL SULFATE; SOLUBILITY;

EID: 51349098915     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-103887     Document Type: Article

References (54)

1. Gatchel, J. R., and Zoghbi, H. Y. (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743-755
2. Zoghbi, H. Y., and Orr, H. T. (2000) Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217-247
3. Butler, R., and Bates, G. P. (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat. Rev. Neurosci. 7, 784-796
4. Riley, B. E., and Orr, H. T. (2006) Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Gene Dev. 20, 2183-2192
5. Huen, N. Y., Wong, S. L., and Chan, H. Y. (2007) Transcriptional malfunctioning of heat shock protein gene expression in spinocerebellar ataxias. Cerebellum 6, 111-117
6. Brignull, H. R., Morley, J. F., and Morimoto, R. I. (2007) The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv. Exp. Med. Biol. 594, 167-189
7. Rubinsztein, D. C. (2006) The roles of intracellular proteindegradation pathways in neurodegeneration. Nature 443, 780-786
8. Nagai, Y., Inui, T., Popiel, H. A., Fujikake, N., Hasegawa, K., Urade, Y., Goto, Y., Naiki, H., and Toda, T. (2007) A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332-340
9. Ehrnhoefer, D. E., Duennwald, M., Markovic, P., Wacker, J. L., Engemann, S., Roark, M., Legleiter, J., Marsh, J. L., Thompson, L. M., Lindquist, S., Muchowski, P. J., and Wanker, E. E. (2006) Green tea (-)-epigallocatechin- gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15, 2743-2751
10. Mukai, H., Isagawa, T., Goyama, E., Tanaka, S., Bence, N. F., Tamura, A., Ono, Y., and Kopito, R. R. (2005) Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 102, 10887-10892
11. Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., and Muchowski, P. J. (2004) Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 11, 1215-1222
12. Li, M., Chevalier-Larsen, E. S., Merry, D. E., and Diamond, M. I. (2006) Soluble androgen receptor oligomers underlie pathology in a mouse model of SBMA. J. Biol. Chem. 282, 3157-3164
13. Poirier, M. A., Li, H., Macosko, J., Cai, S., Amzel, M., and Ross, C. A. (2002) Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem. 277, 41032-41037
14. Diaz-Hernandez, M., Moreno-Herrero, F., Gomez-Ramos, P., Moran, M. A., Ferrer, I., Baro, A. M., Avila, J., Hernandez, F., and Lucas, J. J. (2004) Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain. J. Neurosci. 24, 9361-9371
15. Michalik, A., and Van Broeckhoven, C. (2003) Pathogenesis of polyglutamine disorders: aggregation revisited. Hum. Mol. Genet. 12(Spec. 2), R173-R186
16. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810
17. Ross, C. A., and Poirier, M. A. (2005) Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell. Biol. 6, 891-898
18. Slow, E. J., Graham, R. K., and Hayden, M. R. (2006) To be or not to be toxic: aggregations in Huntington and Alzheimer disease. Trends Genet. 22, 408-411
19. Weydt, P., and La Spada, A. R. (2006) Targeting protein aggregation in neurodegeneration-lessons from polyglutamine disorders. Expert Opin. Ther. Targets 10, 505-513
20. Chan, H. Y., Warrick, J. M., Andriola, I., Merry, D., and Bonini, N. M. (2002) Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11, 2895-2904
21. Chan, H. Y., Warrick, J. M., Gray-Board, G. L., Paulson, H. L., and Bonini, N. M. (2000) Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9, 2811-2820
22. Hazeki, N., Tukamoto, T., Goto, J., and Kanazawa, I. (2000) Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. Biochem. Biophys. Res. Comm. 277, 386-393
23. Hoffner, G., Island, M. L., and Djian, P. (2005) Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers. J. Neurochem. 95, 125-136
24. Iuchi, S., Hoffner, G., Verbeke, P., Djian, P., and Green, H. (2003) Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine. Proc. Natl. Acad. Sci. U. S. A. 100, 2409-2414
25. Warrick, J. M., Paulson, H. L., Gray-Board, G. L., Bui, Q. T., Fischbeck, K. H., Pittman, R. N., and Bonini, N. M. (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939-949
26. Wong, S. L., Chen, Y., Chan, C. M., Chan, C. S., Chan, P. K., Chui, Y. L., Fung, K. P., Waye, M. M., Tsui, S. K., and Chan, H. Y. (2005) In vivo functional characterization of the SARS-Corona-virus 3a protein in Drosophila. Biochem. Biophys. Res. Comm. 337, 720-729
27. Huen, N. Y., and Chan, H. Y. (2005) Dynamic regulation of molecular chaperone gene expression in polyglutamine disease. Biochem. Biophys. Res. Comm. 334, 1074-1084
28. Velazquez, J. M., Sonoda, S., Bugaisky, G., and Lindquist, S. (1983) Is the major Drosophila heat shock protein present in cells that have not been heat shocked? J. Cell. Biol. 96, 286-290
29. Berger, Z., Ttofi, E. K., Michel, C. H., Pasco, M. Y., Tenant, S., Rubinsztein, D. C., and O'Kane, C. J. (2005) Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway. Hum. Mol. Genet. 14, 3003-3011
30. Warrick, J. M., Chan, H. Y., Gray-Board, G. L., Chai, Y., Paulson, H. L., and Bonini, N. M. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23, 425-428
31. McGuire, S. E., Mao, Z., and Davis, R. L. (2004) Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci. STKE 2004, pl6
32. Agrawal, N., Pallos, J., Slepko, N., Apostol, B. L., Bodai, L., Chang, L. W., Chiang, A. S., Thompson, L. M., and Marsh, J. L. (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl. Acad. Sci. U. S. A. 102, 3777-3781
33. Apostol, B. L., Kazantsev, A., Raffioni, S., Illes, K., Pallos, J., Bodai, L., Slepko, N., Bear, J. E., Gertler, F. B., Hersch, S., Housman, D. E., Marsh, J. L., and Thompson, L. M. (2003) A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 100, 5950-5955
34. Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B. O., Muller, E. C., Lurz, R., Breuer, P., Schugardt, N., Plassmann, S., Xu, K., Warrick, J. M., Suopanki, J., Wullner, U., Frank, R., Hartl, U. F., Bonini, N. M., and Wanker, E. E. (2006) An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 25, 1547-1558
35. Jackson, G. R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P. W., MacDonald, M. E., and Zipursky, S. L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642
36. Slepko, N., Bhattacharyya, A. M., Jackson, G. R., Steffan, J. S., Marsh, J. L., Thompson, L. M., and Wetzel, R. (2006) Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc. Natl. Acad. Sci. U. S. A. 103, 14367-14372
37. Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y. Z., Greenwald, M., Kurokawa, R., Housman, D. E., Jackson, G. R., Marsh, J. L., and Thompson, L. M. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743
38. Wolfgang, W. J., Miller, T. W., Webster, J. M., Huston, J. S., Thompson, L. M., Marsh, J. L., and Messer, A. (2005) Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. Proc. Natl. Acad. Sci. U. S. A. 102, 11563-11568
39. Bukau, B., Weissman, J., and Horwich, A. (2006) Molecular chaperones and protein quality control. Cell 125, 443-451
40. Young, J. C., Agashe, V. R., Siegers, K., and Hartl, F. U. (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell. Biol. 5, 781-791
41. Klucken, J., Shin, Y., Hyman, B. T., and McLean, P. J. (2004) A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity. Biochem. Biophys. Res. Comm. 325, 367-373
42. Bilen, J., and Bonini, N. M. (2005) Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153-171
43. Warrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., and Bonini, N. M. (2005) Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18, 37-48
44. Ross, C. A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819-822
45. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10-17
46. Jana, N. R., Tanaka, M., Wang, G., and Nukina, N. (2000) Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018
47. Rub, U., de Vos, R. A., Brunt, E. R., Sebesteny, T., Schols, L., Auburger, G., Bohl, J., Ghebremedhin, E., Gierga, K., Seidel, K., den Dunnen, W., Heinsen, H., Paulson, H., and Deller, T. (2006) Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Brain Pathol. 16, 218-227
48. Behrends, C., Langer, C. A., Boteva, R., Bottcher, U. M., Stemp, M. J., Schaffar, G., Rao, B. V., Giese, A., Kretzschmar, H., Siegers, K., and Hartl, F. U. (2006) Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell 23, 887-897
49. Sanchez, I., Mahlke, C., and Yuan, J. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379
50. Taylor, J. P., Tanaka, F., Robitschek, J., Sandoval, C. M., Taye, A., Markovic-Plese, S., and Fischbeck, K. H. (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757
51. Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G. P., Lehrach, H., and Wanker, E. E. (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. U. S. A. 96, 4604-4609
52. Muchowski, P. J., Schaffar, G., Sittler, A., Wanker, E. E., Hayer-Hartl, M. K., and Hartl, F. U. (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. U. S. A. 97, 7841-7846
53. Schaffar, G., Breuer, P., Boteva, R., Behrends, C., Tzvetkov, N., Strippel, N., Sakahira, H., Siegers, K., Hayer-Hartl, M., and Hartl, F. U. (2004) Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95-105
54. Ellisdon, A. M., Thomas, B., and Bottomley, S. P. (2006) The 2-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J. Biol. Chem. 281, 16888-16896